Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

IMPORTANCE: Most patients with atrial fibrillation (AF) and coronary artery disease have indications for preventing stroke with oral anticoagulation therapy and preventing myocardial infarction and stent thrombosis with platelet inhibition. OBJECTIVE: To evaluate whether the recently developed ABC (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hijazi, Ziad, Oldgren, Jonas, Lindbäck, Johan, Alexander, John H., Alings, Marco, De Caterina, Raffaele, Eikelboom, John W., Ezekowitz, Michael D., Held, Claes, Huber, Kurt, Hylek, Elaine M., Granger, Christopher B., Lopes, Renato D., Vinereanu, Dragos, Siegbahn, Agneta, Wallentin, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495236/
https://www.ncbi.nlm.nih.gov/pubmed/32936298
http://dx.doi.org/10.1001/jamanetworkopen.2020.15943

Ejemplares similares

Ejemplares similares